A high proportion of polymorphisms in the promoters of brain expressed genes influences transcriptional activity

被引:56
作者
Buckland, PR
Hoogendoom, B
Guy, CA
Coleman, SL
Smith, SK
Buxbaum, JD
Haroutunian, V
O'Donovan, MC
机构
[1] Cardiff Univ, Dept Med Psychol, Cardiff CF14 4XN, S Glam, Wales
[2] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10021 USA
[3] Bronx Vet Affairs Med Ctr, MIRECC, Bronx, NY 10468 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 2004年 / 1690卷 / 03期
基金
英国医学研究理事会;
关键词
Tf; NPY; PCSK1; NEFL; LM04; HSPA1B;
D O I
10.1016/j.bbadis.2004.06.023
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
There is increasing interest in the possibility that polymorphisms affecting gene expression are responsible for a significant proportion of heritable human phenotypic variation, including human disease. We have sought to determine if polymorphisms in the promoters of brain expressed genes are commonly functional. We screened for polymorphism 56 genes previously reported to be differentially expressed in the brains of schizophrenics [Y Hakak, JR. Walker, C. Li, W.H. Wong, K.L. Davis, J.D. Buxbaum, V Haroutunian, A.A. Fienberg, Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc. Natl. Acad. Sci. 98 (2001) 4746-4751.]. We found 60 variants distributed across 31 of the genes. A total of 77 haplotypes representing 28 different putative promoters were analyzed in a reporter gene assay in two. cell lines. Of a total of 54 sequence variants represented in the haplotypes, 12 (or around 22%) were functional according to a highly conservative definition. These were found in the promoters of eight genes: NPY, PCSK1, NEFL, KIAA0513, LMO4, HSPA1B, TF and MDH1. We therefore estimate that around 20-25% of promoter polymorphisms in brain expressed genes are functional, and this is likely to be an underestimate. Our data therefore provide for the first time empirical evidence that promoter element polymorphisms, at least in brain expressed genes, should be afforded a high priority for molecular genetic studies. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:238 / 249
页数:12
相关论文
共 35 条
[1]   Computer model for recognition of functional transcription start sites in RNA polymerase II promoters of vertebrates [J].
Bajic, VB ;
Seah, SH ;
Chong, A ;
Krishnan, SPT ;
Koh, JLY ;
Brusic, V .
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2003, 21 (05) :323-332
[2]   A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain [J].
Bray, NJ ;
Buckland, PR ;
Williams, NM ;
Williams, HJ ;
Norton, N ;
Owen, MJ ;
O'Donovan, MC .
AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (01) :152-161
[3]   Location of a major susceptibility locus for familiar schizophrenia on chromosome 1q21-q22 [J].
Brzustowicz, LM ;
Hodgkinson, KA ;
Chow, EWC ;
Honer, WG ;
Bassett, AS .
SCIENCE, 2000, 288 (5466) :678-682
[4]   The downstream core promoter element, DPE, is conserved from Drosophila to humans and is recognized by TAF(II)60 of Drosophila [J].
Burke, TW ;
Kadonaga, JT .
GENES & DEVELOPMENT, 1997, 11 (22) :3020-3031
[5]   Association and linkage analyses of RGS4 polymorphisms in schizophrenia [J].
Chowdari, KV ;
Mirnics, K ;
Semwal, P ;
Wood, J ;
Lawrence, E ;
Bhatia, T ;
Deshpande, SN ;
K, TB ;
Ferrell, RE ;
Middleton, FA ;
Devlin, B ;
Levitt, P ;
Lewis, DA ;
Nimgaonkar, VL .
HUMAN MOLECULAR GENETICS, 2002, 11 (12) :1373-1380
[6]   Experimental analysis of the annotation of promoters in the public database [J].
Coleman, SL ;
Buckland, PR ;
Hoogendoorn, B ;
Guy, C ;
Smith, K ;
O'Donovan, MC .
HUMAN MOLECULAR GENETICS, 2002, 11 (16) :1817-1821
[7]   Streamlined approach to functional analysis of promoter-region polymorphisms [J].
Coleman, SL ;
Hoogen-doorn, B ;
Guy, C ;
Smith, SK ;
O'Donovan, MC ;
Buckland, PR .
BIOTECHNIQUES, 2002, 33 (02) :412-+
[8]   White matter changes in schizophrenia - Evidence for myelin-related dysfunction [J].
Davis, KL ;
Stewart, DG ;
Friedman, JI ;
Buchsbaum, M ;
Harvey, PD ;
Hof, PR ;
Buxbaum, J ;
Haroutunian, V .
ARCHIVES OF GENERAL PSYCHIATRY, 2003, 60 (05) :443-456
[9]   Neuropeptides involved in the pathophysiology of schizophrenia and major depression [J].
De Wied, David ;
Sigling, Hein O. .
NEUROTOXICITY RESEARCH, 2002, 4 (5-6) :453-468
[10]   Inhibition of C-protein-mediated MAP kinase activation by a new mammalian gene family [J].
Druey, KM ;
Blumer, KJ ;
Kang, VH ;
Kehrl, JH .
NATURE, 1996, 379 (6567) :742-746